To hear about similar clinical trials, please enter your email below
Trial Title:
Preliminary Study on the Diagnostic Value Comparison of 18F-FAPI-04 PET/CT and PET/MR in Gastric Cancer
NCT ID:
NCT06543108
Condition:
Gastric Cancer
Conditions: Official terms:
Stomach Neoplasms
Study type:
Observational
Overall status:
Recruiting
Study design:
Time perspective:
Prospective
Intervention:
Intervention type:
Diagnostic Test
Intervention name:
The clinical value of 18F-FAPI-04 PET/CT and PET/MR imaging in the diagnosis and staging of gastric cancer
Description:
The clinical value of 18F-FAPI-04 PET/CT and PET/MR imaging in the diagnosis and staging
of gastric cancer
Summary:
This project aims to comprehensively analyze the diagnostic efficacy of SUVmax, SUVean,
TLG, MTV, etc. in gastric cancer through 18F-FAPI-04 PET/CT imaging combined with serum
tumor markers and other methods, and construct a molecular imaging diagnostic model for
gastric cancer; Next, analyze the diagnostic efficacy of 18F-FAPI-04 PET/CT and PET/MR
multimodal imaging in evaluating SUVmax, PET/CT-PCI, and PET/MR-PCI for gastric cancer
peritoneal metastasis, and construct a molecular imaging diagnostic model for gastric
cancer peritoneal metastasis; Exploring the clinical value of 18F-FAPI-04 PET/CT and
PET/MR imaging in the diagnosis and staging of gastric cancer.
Criteria for eligibility:
Study pop:
Gastric cancer
Sampling method:
Probability Sample
Criteria:
Inclusion Criteria:
1. Age over 18 years old;
2. Diagnosed as a patient with gastric cancer;
3. Receive FAPI PET/CT and FDG PET/CT imaging within one week;
4. Perform serum tumor marker testing one week before and after scanning
Exclusion Criteria:
1. History of other malignant tumors;
2. Patients with severe infections, severe underlying diseases such as heart, kidney,
and liver;
3. Patients with contraindications for PET-CT examination, poor physical condition, and
inability to tolerate the examination;
4. Patients with unorganized pathology or incomplete clinical data
Gender:
All
Minimum age:
18 Years
Maximum age:
90 Years
Healthy volunteers:
No
Locations:
Facility:
Name:
Hunan Cancer hospital
Address:
City:
Changsha
Zip:
410000
Country:
China
Status:
Recruiting
Contact:
Last name:
Hui Ye
Phone:
86-13755117105
Email:
yuxin75831@163.com
Start date:
January 1, 2024
Completion date:
December 31, 2028
Lead sponsor:
Agency:
Hunan Cancer Hospital
Agency class:
Other
Source:
Hunan Cancer Hospital
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT06543108
